Ignite Creation Date:
2024-05-06 @ 9:11 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02920125
Status:
COMPLETED
Last Update Posted:
2017-09-26
First Post:
2016-09-28
Brief Title:
Study the Result of Ayurvedic SUVED Reimmugen Colostrum Treatment on Vascular Disease CAD CVA DVT
Sponsor:
Sujata Vaidya
Organization:
Health Solutions India
Study Overview
Official Title:
A Study to Evaluate the Results of Integrative Treatment by Including Ayurvedic Capsules Suved Reimmugen for Vascular Disease Namely Cerebro Vascular Accident - Embolic and Atherosclerotic CVA CAD IHDDVT
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SHARP
Brief Summary:
To evaluate the benefits of Ayurvedic SUVED REIMMUGEN Colostrum for reductionreversal of symptoms and study clinical progress in Vascular disease CAD CAV Stroke DVT patients
Detailed Description:
Aim A non-invasive effective compatible Integrative treatment option to address the growing burden of Vascular disease Importance Ayurvedic SUVED cardio tonic continuous clotlysis endothelial repair powerful rejuvenator antioxidant and Reimmugen Cow Colostrum - IgG GF provides sustained Functional symptomatic relief with clinical reports of regression of disease No adverse interactions reported
Application Addition of SUVED REIMMUGEN helps in
Acute MI Thrombotic stroke DVT hastens symptomatic recovery reduces hospitalization time mortality helps dissolve clots soft thrombus reversal of atherosclerotic plaques improves functional life
Improvements in Cardiac Function LVEF Global perfusion
Rejuvenation of endothelium vascular function
Improved physical strength digestion GI function immunity accelerated internal healing
Secondary prevention to avoid incidences in post event treatment
Health conditionproblem studied Vascular disease esp CVA IHD CAD DVT PAD Volunteers taken from OPD and IPD of SKNMC GH with prior consent for participation
Intervention is Medicament based given in addition to conventional ongoing therapy under the guidance of SKNMC doctors
Study type Clinical trial Double Blind placebo controlled trial Interventional Trial regular treatment Evaluation of additional Integrative esp Ayurvedic medicaments on clinical and functional outcome
Intervention and comparator agent
1 Ayurvedic ghana formulation named SUVED
2 Whole Cow Colostrum called Reimmugen These will be given for a period of three months in addition to ongoing medication to study the additional benefit to patient in their functional and clinical investigations
The control interventions isare the interventions against which the study intervention is evaluated as double blind placebo
Suved 1 BD for 3 months Reimmugen 1 TDS for 3 months In acute cases Suved 1 TDS Reimmugen 2 TDS for 3 months Inclusion Exclusion criteria Inclusion criteria
Adult males or females with a diagnosis of Vascular disease leading to IHD CAD CVA DVT PAD at any stage
Exclusion Criteria
Pregnant and lactating women Patients below age of 18 Acute IPD operative condition Patients undergoing interventional procedures surgical treatments other than for Vascular disease until they are discharged from intensive care Haemorrhagic cerebro vascular stroke
Application Addition of SUVED REIMMUGEN helps in
Acute MI Thrombotic stroke DVT hastens symptomatic recovery reduces hospitalization time mortality helps dissolve clots soft thrombus reversal of atherosclerotic plaques improves functional life
Improvements in Cardiac Function LVEF Global perfusion
Rejuvenation of endothelium vascular function
Improved physical strength digestion GI function immunity accelerated internal healing
Secondary prevention to avoid incidences in post event treatment
Health conditionproblem studied Vascular disease esp CVA IHD CAD DVT PAD Volunteers taken from OPD and IPD of SKNMC GH with prior consent for participation
Intervention is Medicament based given in addition to conventional ongoing therapy under the guidance of SKNMC doctors
Study type Clinical trial Double Blind placebo controlled trial Interventional Trial regular treatment Evaluation of additional Integrative esp Ayurvedic medicaments on clinical and functional outcome
Intervention and comparator agent
1 Ayurvedic ghana formulation named SUVED
2 Whole Cow Colostrum called Reimmugen These will be given for a period of three months in addition to ongoing medication to study the additional benefit to patient in their functional and clinical investigations
The control interventions isare the interventions against which the study intervention is evaluated as double blind placebo
Suved 1 BD for 3 months Reimmugen 1 TDS for 3 months In acute cases Suved 1 TDS Reimmugen 2 TDS for 3 months Inclusion Exclusion criteria Inclusion criteria
Adult males or females with a diagnosis of Vascular disease leading to IHD CAD CVA DVT PAD at any stage
Exclusion Criteria
Pregnant and lactating women Patients below age of 18 Acute IPD operative condition Patients undergoing interventional procedures surgical treatments other than for Vascular disease until they are discharged from intensive care Haemorrhagic cerebro vascular stroke
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1187-7158 | OTHER | WHO | None |